Health Condition 1: null- ATTENUATION DURING ANESTHESIA IN LAPROSCOPIC CHOLECYSTECTOMY
Conditions
Interventions
Intervention1: Inj magnesium sulphate: Inj magnesium sulphate 40mg/kg over 15 min in 20 ml NS intravenously
Control Intervention1: INJ DEXMEDETOMIDINE
: Inj Dexmedetomidine 1mcg/kg over 15 min in 20 m
Sponsors
SSG HOSPITAL VADODARA
Eligibility
Inclusion criteria
Inclusion criteria: 1 Age Group 18 -65years 2 ASA status I & II 3 Male / female Patients posted for laparoscopic cholecystectomy
Exclusion criteria
Exclusion criteria: • Anticipated difficult airway and obesity • Patient having allergy to study drug • Patient with systemic diseases like severe hypertension, cardiovascular, respiratory, neurological, psychological, hepatic, renal disease (diagnosed by clinical judgments and investigations) and on medication of above mentioned diseases • Patients with heart rate • Pregnant or lactating females • Patients who refuse to give consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It will be expected that both drugs will be effectively able to attenuate hemodynamic stress response during anaesthesia for laparoscopic cholecystectomy with CO2 pneumoperitoneumTimepoint: 1. Baseline 2. Before and after infusion 3. Before and after intubation 4. Before and after Pneumoperitoneum 5. After release of Pneumoperitoneum 6. After Extubation | — |
Secondary
| Measure | Time frame |
|---|---|
| 1Amount of induction agent used 2Post-operative sedation â??Ramsay sedation score â?¢ Post-operative Analgesia-Visual analogue scaleTimepoint: 1min,15min,30min,60min,120min | — |
Countries
India
Contacts
Public Contactshailee shah
SSG HOSPITAL,VADODARA
Outcome results
None listed